Journal for Immunotherapy of Cancer. 8 (1): e000695. doi:10.1136/jitc-2020-000695. ISSN 2051-1426. PMC 7254113. PMID 32273348. ... supporting the TAM receptor pathway as an upstream target for immunotherapy. In 2017, Rothlin and her team showed further roles ...
Frankland continued to publish; at age 100 he authored "100 years of allergen immunotherapy", and most recently co-authored, " ... Frankland, W.A. (2013). "100 years of allergen immunotherapy". J. Biol. Phys. Chem. 13 (2): 53-60. doi:10.4024/36FR12A.jbpc. ... one of the contributing factors to Frankland being awarded the EAACI Noon Award for significant contributions to immunotherapy ...
This is called passive immunotherapy. However, these treatments have inherent problems; passive antibody exposes the body to ...
DC-based immunotherapy approach can be employed in a couple of ways: Many trials evaluating in vivo DC stimulation with ... DC-based immunotherapy is safe and can promote antitumor immune responses and prolonged survival of cancer patients. Non- ... Palucka, Karolina; Banchereau, Jacques (2012-03-22). "Cancer immunotherapy via dendritic cells". Nature Reviews. Cancer. 12 (4 ... "Cancer Immunotherapy: Sipuleucel-T and Beyond". Pharmacotherapy. 31 (8): 813-828. doi:10.1592/phco.31.8.813. ISSN 0277-0008. ...
Parker Institute for Cancer Immunotherapy. Retrieved 2019-06-17. "Immunotherapy Expert Crystal Mackall, MD, Joins Stanford ... Baldrick's-StandUp2Cancer Team 2021 Richard V. Smalley Award and Lectureship, The Society for the Immunotherapy of Cancer's " ... Mackall has pioneered cancer immunotherapies for children. Her early research defined the effects of traditional cancer ... Parker Institute for Cancer Immunotherapy. Retrieved 2019-06-17.[verification needed] "Crystal Mackall". stanfordhealthcare.org ...
The main focus of his research work is the discovery of mRNA-based drugs for use as individualized cancer immunotherapies, as ... Its focus is on individualized medicine and cancer immunotherapy. For his work in this field, Şahin was awarded the German ... He received his doctorate in 1992 with a thesis on immunotherapy against tumor cells (bispecific monoclonal antibodies for the ... BioNTech is focused on developing and manufacturing active immunotherapies for a patient-specific approach to the treatment of ...
June 2018). "Cytokine release syndrome". Journal for Immunotherapy of Cancer. 6 (1): 56. doi:10.1186/s40425-018-0343-9. PMC ... severe side effects of modern targeted and immunotherapy of cancer and their management". Critical Care. 21 (1): 89. doi: ...
Thus they serve as immunomodulators in immunotherapy (therapy that makes use of immune responses), which can be helpful in ... Immunotherapy "Biological Response Modifiers (BRM)". Shamliyan, Tatyana A.; Dospinescu, Paula (July 2017). "Additional ... "Immunotherapy makes use of BRMs to enhance the activity of the immune system to increase the body's natural defense mechanisms ...
Journal for Immunotherapy of Cancer. 7 (1): 201. doi:10.1186/s40425-019-0668-z. PMC 6670138. PMID 31366386. Catalan-Dibene J, ...
"Cancer Immunotherapy Partnerships and Collaborations". Society for Immunotherapy of Cancer. Archived from the original on 2023- ... AIM is a partner of the Society for Immunotherapy of Cancer. In the first quarter of 2021, the foundation received a $10,000 ...
Thus, tumor-derived Hsp70 has been suggested as a potential vaccine or avenue to target for immunotherapy. Given the increased ... December 2007). "Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer ... Guzhova IV, Margulis BA (October 2016). "HSP70-based anti-cancer immunotherapy". Human Vaccines & Immunotherapeutics. 12 (10): ...
Journal for ImmunoTherapy of Cancer. 1 (Suppl 1): 210. doi:10.1186/2051-1426-1-S1-P210. PMC 3991175. James Watson, Tania Baker ...
Baecher-Allan C, Kaskow BJ, Weiner HL (February 2018). "Multiple Sclerosis: Mechanisms and Immunotherapy". Neuron. 97 (4): 742- ... March 2020). "Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies". Trends in Molecular Medicine. 26 ...
Journal for Immunotherapy of Cancer. 7 (1): 104. doi:10.1186/s40425-019-0576-2. PMC 6477737. PMID 31010434. "ASCPT News". ...
Allergy immunotherapy can be administered orally (as sublingual tablets or sublingual drops), or by injections under the skin ( ... Allergen immunotherapy treatment involves administering doses of allergens to accustom the body to induce specific long-term ... Dhillon, M. (May 1991). "Current status of mold immunotherapy". Ann Allergy. 66 (5): 385-92. PMID 2035901. Gupta, SK.; Pereira ... Immune mechanisms of allergen-specific sublingual immunotherapy. Revue française d'allergologie et d'immunologie clinique. 2006 ...
"Cancer Immunotherapy Partnerships and Collaborations". Society for Immunotherapy of Cancer. Archived from the original on 27 ... and a partner of the Society for Immunotherapy of Cancer and Vaccine Confidence Project. A single evaluation is carried out ...
Waldman, Thomas A. (2003). "Immunotherapy: past, present and future". Nature Medicine. 9 (3): 269-277. doi:10.1038/nm0303-269. ...
Evolutionary medicine § tradeoffs Immunotherapy Infectious tolerance Mithridatism Plant tolerance to herbivory Medawar, Peter ( ... Ramsay, AG (2013). ". Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity". Br J Haematol. 162 (3 ... Petalas, K; Durham SR (2013). "Allergen immunotherapy for allergic rhinitis". Rhinology. 51 (2): 99-110. doi:10.4193/ ...
Immunotherapy is a method that activates the person's immune system and uses it to their own advantage. It was developed after ... Immunotherapy and targeted therapy have improved the outlook for metastatic RCC. RCC is also associated with a number of ... Immunotherapy capitalises on this phenomenon and aims to build up a person's immune response to cancer cells. Other targeted ... RCC is resistant to chemotherapy and radiotherapy in most cases but does respond well to immunotherapy with interleukin-2 or ...
This is called oral immunotherapy (OIT). Sublingual immunotherapy, in which the allergenic protein is held in the mouth under ... acaai.org/allergies/allergy-treatment/allergy-immunotherapy/sublingual-immunotherapy-slit/ Sublingual Therapy (SLIT) American ... Oral immunotherapy is being researched, but it is of unclear benefit. Food allergies can be classified as rapid-onset (with ... March 2012). "Oral immunotherapy for IgE-mediated cow's milk allergy: a systematic review and meta-analysis". Clinical and ...
Allergen immunotherapy Arsenikesser ("arsenic eater"; German Wikipedia) Hormesis Hydra effect Mithridate Vaccination Smith, ...
Chen R, Ganesan A, Okoye I, Arutyunova E, Elahi S, Lemieux MJ, Barakat K (March 2020). "Targeting B7-1 in immunotherapy". ... The triggering of Natural Killer cell-mediated death via CD80 interactions has been explored as possible cancer immunotherapy ... Developing Costimulatory Molecules for Immunotherapy of Diseases. Elsevier: 1-43. doi:10.1016/b978-0-12-802585-7.00001-7. ISBN ...
Institute of Immunology and Immunotherapy; Institute of Metabolism and Systems Research; Institute of Microbiology and ...
Journal for Immunotherapy of Cancer. 5 (1): 53. doi:10.1186/s40425-017-0257-y. PMC 5514481. PMID 28716061. Ridge SA, Worwood M ...
Klingemann H, Boissel L, Toneguzzo F (2016). "Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over ... Several phase 1 clinical trials have been performed by experts in the field of adoptive immunotherapy of cancer. Hans ... Paul S, Lal G (2017). "The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy". ... April 2020). "Overcoming hypoxia-induced functional suppression of NK cells". Journal for Immunotherapy of Cancer. 8 (1): ...
Journal for Immunotherapy of Cancer. 6 (1): 47. doi:10.1186/s40425-018-0356-4. PMC 5987416. PMID 29866156. (Articles with short ...
Immunotherapy is another potential approach. Monoclonal antibodies against Junin virus have been tested in animal models. An ... "Rational design of universal immunotherapy for TfR1-tropic arenaviruses". Nature Communications. 11 (1): 67. Bibcode:2020NatCo ...
Qi X, Li F, Wu Y, Cheng C, Han P, Wang J, Yang X (May 2019). "Optimization of 4-1BB antibody for cancer immunotherapy by ... Yonezawa A, Dutt S, Chester C, Kim J, Kohrt HE (July 2015). "Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy". ... Journal for Immunotherapy of Cancer. 8 (Suppl 3). doi:10.1136/jitc-2020-SITC2020.0647. S2CID 228992726. (Articles with short ... Urelumab is an innovative and promising cancer immunotherapy. The first phase I trial of Urelumab began in 2006 and final ...
The activation immunotherapies can revive and enhance immune cell function. Comparing to other immunotherapies, therapies ... Broussard, Grant; Damania, Blossom (2020-02-07). "KSHV: Immune Modulation and Immunotherapy". Frontiers in Immunology. 10: 3084 ...
"About". Focused Ultrasound Cancer Immunotherapy Center. Retrieved 2023-01-20. Jackson, Christina (2020-07-15). "Scientists ... and with the School of Medicine's Focused Ultrasound Cancer Immunotherapy Center. UVA Cancer Center's research findings include ...